Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000343071 | SCV000412101 | likely benign | Central core myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000376680 | SCV000412102 | likely benign | Malignant hyperthermia of anesthesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000284547 | SCV000412103 | likely benign | Neuromuscular disease, congenital, with uniform type 1 fiber | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000337726 | SCV000412104 | likely benign | Multiminicore myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000433314 | SCV000527817 | likely benign | not specified | 2017-08-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000721519 | SCV000852599 | likely benign | not provided | 2016-09-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086423 | SCV001002661 | likely benign | RYR1-related disorder | 2024-01-02 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995865 | SCV004815124 | likely benign | Malignant hyperthermia, susceptibility to, 1 | 2024-02-05 | criteria provided, single submitter | clinical testing |